🇧🇷 Rozlytrek in Brazil

Rozlytrek (entrectinib) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Rozlytrek in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Brazil

Frequently asked questions

Is Rozlytrek approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Rozlytrek in Brazil?

Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.